The ACME Laboratories Ltd. (DSE: ACMELAB)

The ACME Laboratories Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Cash & Equivalents	1,465	1,455	1,239	1,594	1,824	1,378
Short-Term Investments	1,268	50.45	48.14	180.12	278.07	524.2
Cash & Short-Term Investments	2,733	1,506	1,287	1,774	2,102	1,902
Cash Growth	19.65%	17.00%	-27.45%	-15.60%	10.51%	-15.25%
Accounts Receivable	3,045	2,705	2,236	2,216	1,911	1,600
Other Receivables	19.86	19.89	19.81	19.93	19.73	20.3
Receivables	3,065	2,725	2,256	2,236	1,931	1,620
Inventory	11,272	10,234	7,879	5,124	5,231	4,335
Prepaid Expenses	26.03	15.61	14.01	13.09	12.06	18.33
Other Current Assets	6,527	6,655	5,907	6,193	5,430	4,261
Total Current Assets	23,623	21,136	17,343	15,341	14,706	12,136
Property, Plant & Equipment	30,621	29,243	25,599	25,100	24,689	23,752
Long-Term Investments	31.13	31.52	32.88	35.51	23.77	33.88
Other Intangible Assets	-	-	0	0.02	0.04	0.08
Total Assets	54,276	50,410	42,975	40,476	39,418	35,922
Accounts Payable	485.87	490.89	449	350.25	398.97	321.41
Accrued Expenses	591.2	553.26	574.63	508.59	419.86	233.74
Short-Term Debt	14,424	12,523	9,383	7,141	8,315	8,288
Current Portion of Long-Term Debt	2,194	2,054	2,328	2,601	2,459	2,123
Current Portion of Leases	21.36	21.86	22.33	14.27	11.64	-
Current Income Taxes Payable	3,815	3,255	2,661	2,856	2,367	2,012
Current Unearned Revenue	-	48.2	14.46	8.33	3.19	5.66
Other Current Liabilities	3.87	6.51	4.38	7.23	6.74	17.32
Total Current Liabilities	21,536	18,953	15,438	13,487	13,982	13,000
Long-Term Debt	6,212	6,168	4,175	5,442	5,107	3,557
Long-Term Leases	49.48	62.29	73.2	62.88	66.78	-
Long-Term Deferred Tax Liabilities	798.2	903.14	907.59	873.54	857.26	684.49
Total Liabilities	29,874	27,115	21,285	20,366	20,374	17,578
Common Stock	2,116	2,116	2,116	2,116	2,116	2,116
Additional Paid-In Capital	5,128	5,128	5,128	5,128	5,128	5,128
Retained Earnings	12,171	11,029	9,304	7,675	6,564	5,773
Comprensive Income & Other	4,988	5,022	5,142	5,192	5,237	5,327
Total Common Equity	24,402	23,295	21,690	20,111	19,044	18,343
Shareholders' Equity	24,402	23,295	21,690	20,111	19,044	18,343
Total Liabilities & Equity	54,276	50,410	42,975	40,476	39,418	35,922
Total Debt	22,901	20,829	15,982	15,262	15,960	13,967
Net Cash (Debt)	-20,167	-19,324	-14,694	-13,488	-13,858	-12,065
Net Cash Per Share	-95.31	-91.32	-69.44	-63.74	-65.49	-57.02
Filing Date Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Total Common Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Working Capital	2,088	2,182	1,905	1,853	723.73	-864.21
Book Value Per Share	115.32	110.09	102.50	95.04	90.00	86.69
Tangible Book Value	24,402	23,295	21,690	20,111	19,044	18,343
Tangible Book Value Per Share	115.32	110.09	102.50	95.04	90.00	86.69
Land	-	5,233	5,228	4,967	4,954	4,914
Buildings	-	9,649	8,112	6,770	6,618	6,618
Machinery	-	16,538	13,018	12,934	11,967	11,225
Construction In Progress	-	4,367	4,820	5,442	4,912	4,126

Source: S&P Capital IQ. Standard template. Financial Sources.